A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

The season is over for Washington Wizards forward Cam Whitmore, as he recovers from a frightening injury setback. “Washington ...

Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

Dublin, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The "Pulmonary Embolism Market - A Global and Regional Analysis, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global pulmonary embolism ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

The Washington Wizards announced that forward Cam Whitmore will miss the remainder of the season as he recovers from an ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...